Purpose | Patients | Evaluations | Perceived Effectiveness |
---|---|---|---|
Amyotrophic lateral sclerosis | 1 | 1 | |
Human immunodeficiency virus (HIV) | 1 | 0 | |
Melanoma | 1 | 0 |
Side effect severity
Severity | Evaluations | Percentage |
---|---|---|
Severe | 0 | |
Moderate | 0 | |
Mild | 0 | |
None | 1 |
Purpose | Patients | Evaluations | Perceived Effectiveness |
---|---|---|---|
Amyotrophic lateral sclerosis | 1 | 1 | |
Human immunodeficiency virus (HIV) | 1 | 0 | |
Melanoma | 1 | 0 |
Severity | Evaluations | Percentage |
---|---|---|
Severe | 0 | |
Moderate | 0 | |
Mild | 0 | |
None | 1 |